Bettina Berger et al.
January 2021
Diabetes
Other fasting
Fasting is usually considered too risky for people with type 1 diabetes (T1D). However, it is possible that a switch from carbohydrate-based to keto-based energy may be relevant for individuals with T1D. This patient-led research aimed to assess the feasibility, benefits and safety of a seven-day multimodal fasting intervention in individuals with T1D.
The non-randomized controlled pilot study included 20 participants with T1D and 10 without disease. Data were collected before, after and 4 months after the intervention as well as daily during the intervention. 19 people with T1D completed the fast. The study found that β-hydroxybutyrate levels, representative of keto bodies, increased during fasting, while average glucose levels remained in the normal range. The daily insulin dose was significantly reduced during fasting.
Quality of life improved, weight and body mass index decreased, and diastolic blood pressure increased slightly but remained within the healthy range. Temporary fasting-related side effects were reported, with slightly higher prevalence in individuals with T1D compared to the reference group.
Overall, the study demonstrated the feasibility, benefits and safety of a seven-day fast in adults with T1D.
Holger Cramer et al.
August 2022
The study shows that fasting reduces weight, blood pressure & other risk factors and is a good start to lifestyle change.
Intermittent fasting
Metabolism / Stomach / Intestines
Stress / Exhaustion
Martin P. Wegman et al.
April 2015
The study shows that intermittent fasting lowers plasma insulin, slightly increases sirtuins and is well tolerated by healthy people.
Andreas Michalsen
April 2010
The study shows that fasting increases serotonin, opioids and endocannabinoids, which improves mood and relieves chronic pain.